Skip links

Wakefit’s Massive Rs 468 Crore IPO: The Mattress Brand Set to Take India’s D2C Market by Storm

If you thought Wakefit was just another mattress brand, think again. The rapidly growing home-furnishing startup is ready to make a splash on the stock market, aiming to raise a jaw-dropping Rs 468 crore through its Initial Public Offering (IPO). This move could not only reshape India’s booming direct-to-consumer (D2C) sector but also signal a major milestone in the home lifestyle market.

In this article, we’ll break down what Wakefit’s IPO means for investors, why the company’s growth story is so compelling, and why this mattress startup could be the next big name on everyone’s lips.


What Exactly Is Wakefit Planning?

Wakefit, founded in 2016, has grown by leaps and bounds from its origins as a mattress-only startup to a full-scale home furnishing brand. The company filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), signaling its intention to go public.

The fresh capital it aims to raise — Rs 468 crore — will come from a combination of a fresh issue and an offer for sale (OFS) by existing shareholders. The funds raised are expected to fuel expansion plans, boost product innovation, and deepen its reach in both India and global markets.


Who Are The Big Players Selling Shares?

One of the most interesting angles of Wakefit’s IPO is the participation of its biggest investors and founders in the share sale:

  • Peak XV Partners (formerly Sequoia Capital India): The largest external stakeholder holding 22.7% of the company plans to offload roughly 2.5 crore shares — nearly half of the total shares offered in the OFS.
  • Other major investors like Verlinvest (1 crore shares) and Investcorp Growth (54.5 lakh shares) will also be selling their stakes.
  • Wakefit’s co-founders, Ankit Garg and Chaitanya Ramalingegowda, intend to sell a combined 1.21 crore shares, indicating their confidence in taking partial profits while still holding a significant stake.

This mix of investor selling and fresh equity issue will provide liquidity for early backers while giving new investors a chance to own part of the company’s future.


Why Is Wakefit’s Growth Story So Impressive?

Wakefit’s rise mirrors India’s changing consumer preferences, where organized brands and online D2C models are rapidly gaining ground.

  • Revenue Growth: Wakefit posted nearly Rs 971 crore in revenue for the first nine months of FY25. In FY24, the company’s annual revenue surged to Rs 986.3 crore, a massive jump from Rs 199 crore in FY20.
  • Narrowing Losses: Although Wakefit is not yet profitable, its net loss has shrunk dramatically to just Rs 8.8 crore in the latest financial year, indicating operational improvements and scale efficiencies.
  • Product Diversification: While mattresses remain its core product, Wakefit has successfully expanded into furniture, home furnishings, and accessories — broadening its product portfolio and customer base.
  • Strong Customer Trust: With rave reviews for comfort, quality, and price, Wakefit has carved a loyal consumer base, often cited as a pioneer in India’s mattress-in-a-box category.

What Makes Wakefit Different From Other D2C Brands?

Wakefit is not just another online mattress seller. It combines several factors that set it apart:

  • Vertical Integration: From product design to manufacturing and direct online sales, Wakefit controls much of its supply chain, helping it keep costs low and quality high.
  • Data-Driven Innovation: The company uses customer feedback and data analytics to constantly improve its product offerings and marketing strategies.
  • Omnichannel Presence: Beyond online sales, Wakefit has also started exploring physical retail touchpoints, blending digital convenience with in-store experiences.
  • Focus on Customer Experience: Free trials, easy returns, and transparent pricing have made Wakefit a trusted brand, especially in a price-sensitive and quality-conscious market.

What Does This IPO Mean for Investors?

For potential investors, Wakefit’s IPO offers a chance to invest in one of India’s fastest-growing D2C brands. The home furnishing and mattress market is poised for explosive growth, driven by:

  • Increasing Urbanization: More urban consumers with rising incomes seeking convenient and quality home products.
  • Shift to Online Shopping: Digital penetration and growing comfort with e-commerce have fueled direct-to-consumer models.
  • Home Makeovers Trend: Especially post-pandemic, Indians are investing more in home comfort, décor, and wellness.

However, investors should also weigh risks:

  • The company is still narrowing losses and faces competition from both local and international brands.
  • Supply chain disruptions or changing consumer preferences could impact growth.

Still, Wakefit’s strong financials and leadership position make it a compelling story.


What’s Next for Wakefit After the IPO?

Post-IPO, Wakefit is expected to accelerate:

  • Manufacturing Expansion: To meet growing demand and reduce dependency on third-party suppliers.
  • Product Innovation: Launching new furniture categories and smart home products.
  • Geographical Growth: Expanding deeper into tier 2 and 3 cities and potentially exploring international markets.
  • Technology Investments: Enhancing customer experience with AI-powered recommendations, virtual trials, and seamless logistics.

Final Thoughts: Is Wakefit the Next Indian Unicorn?

While Wakefit is not yet a unicorn, its meteoric growth, strong investor backing, and strategic IPO raise put it on the fast track to becoming one. The Rs 468 crore IPO is more than a capital-raising exercise — it’s a declaration that the company is ready to challenge traditional retail and revolutionize India’s home lifestyle space.

For consumers, Wakefit means better sleep and smarter homes. For investors, it could be a golden opportunity to own a piece of the future of India’s booming D2C market.

Stay tuned — this mattress brand is just getting started, and the best is yet to come.


 


 

Leave a comment